An exploratory clinical trial to evaluate the efficacy and safety of the CCI Kit in patients

Not Applicable

Completed

• Conditions: Traumatic cartilage defect of the knee joint and osteochondritis dissecans

• Registration Number: JPRN-jRCT2080224161
• Lead Sponsor: Interstem CO .,Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1)Patients diagnosed with traumatic cartilage defect of the knee joint and osteochondritis dissecans
2)Patients applying microfractures
3)Patients with clinical symptoms in the knee joint
4)Patients with KOOS 5 of 70 or less at screening
5)Patients with a cartilage defect area from 2 cm2 to 9 cm2
etc

Exclusion Criteria

1)Patients diagnosed with osteoarthritis and patients with Kellgren-Lawrence classification stage 2 or higher
2)Patients with inflammatory arthritis associated with autoimmune diseases such as rheumatoid arthritis
3)Patients with cartilage defect in both knee joints
4)Patients with multiple cartilage defect
5)Patients with a bone defect with a depth of 8 mm or more at the cartilage defect site
6)Patients who have a history of surgery for adjustment of joint alignment or who need it
etc

Study & Design

• Study Type: Interventional
• Study Design: Not specified